In just concluded Meeting of the Board Directors of the Company, the board has considered and approved:
1. After through discussion on all the recommendations of the Audit Committee, board decided to make Deccan Remedies Limited (Deccan) as our Subsidiary Company by acquire additional 6.73% equity Shares i.e., 836,165 from the Existing promoter Shareholders group and in turn the Company will hold 51% equity shares of the Deccan.
2. Mr. Arihant Baid, Managing Director of the Company represent Gennex (the Company) in the Board of Deccan to manage the Affairs of the Deccan.
|